TLSA (Tiziana Life Sciences) Insider Ownership: 39.52 % (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TLSA Tiziana Life Sciences Ltd TLSA
23 GF Score
Price $0.98
! 2 Warning Signs
View Full Analysis

What is Tiziana Life Sciences Insider Ownership?

Tiziana Life Sciences TLSA +6.26% 23 Insider Ownership is 39.52 % as of Jul. 28, 2026. GuruFocus rates TLSA with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tiziana Life Sciences's insider ownership is 39.52%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tiziana Life Sciences's Institutional Ownership is 2.46%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tiziana Life Sciences's Float Percentage Of Total Shares Outstanding is 28.58%.

Tiziana Life Sciences Insider Ownership Historical Data

* Premium members only.

The historical data trend for Tiziana Life Sciences's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tiziana Life Sciences Insider Ownership Chart

Tiziana Life Sciences Historical Data

The historical data trend for Tiziana Life Sciences can be seen below:

2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 72.05 72.05 72.05 72.05 72.05 72.05 56.80 56.80 39.52 39.52
TLSA
23GF Score
Tiziana Life Sciences Ltd TLSA
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tiziana Life Sciences Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 39.52 % mean?
Tiziana Life Sciences (TLSA) has a Insider Ownership of 39.52 % as of Jul. 28, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Tiziana Life Sciences and its competitors.
Is Tiziana Life Sciences' Insider Ownership too high?
Tiziana Life Sciences' current Insider Ownership is 39.52 %. Overall, Tiziana Life Sciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Tiziana Life Sciences' Insider Ownership compare to PMN and FBIO?
Tiziana Life Sciences' Insider Ownership of 39.52 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Tiziana Life Sciences and its competitors. Tiziana Life Sciences's current Insider Ownership is 39.52 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tiziana Life Sciences stock overvalued right now?
Tiziana Life Sciences (TLSA) has a current Insider Ownership of 39.52 %. The current Insider Ownership is 39.52 %. Tiziana Life Sciences' overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Tiziana Life Sciences (TLSA), the current Insider Ownership is 39.52 % as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tiziana Life Sciences Business Description

Other Exchanges 0RP:Germany
Address 2 Church Street, Clarendon House, Hamilton, BMU, HM 11
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
23GF Score

Get the complete analysis for TLSA

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.98
Price